Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria
The pharmacokinetics of primaquine have been studied in 13 G6PD normal and 13 G6PD deficient Thai male patients with Plasmodium vivax malaria who were given daily doses of 15 mg of primaquine over 14 d, following a full course of chloroquine. After the first dose (15 mg), primaquine underwent rapid...
Saved in:
Main Authors: | , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/9575 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.9575 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.95752018-02-27T11:28:23Z Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria Kesara Na Bangchang Wasana Songsaeng Aurathai Thanavibul Preecha Choroenlarp Juntra Karbwang Mahidol University Immunology and Microbiology Medicine The pharmacokinetics of primaquine have been studied in 13 G6PD normal and 13 G6PD deficient Thai male patients with Plasmodium vivax malaria who were given daily doses of 15 mg of primaquine over 14 d, following a full course of chloroquine. After the first dose (15 mg), primaquine underwent rapid absorption. Mean values (SD in parentheses) of maximum plasma concentration of 57.7 (7.7) vs. 55.7 (7.4) ng/mL were reached at 2.2 (0.6) vs. 2.2 (0.6) h, for the G6PD deficient and G6PD normal groups, respectively. Thereafter, drug levels declined rapidly and monoexponentially with a t 1/2λ of 6.4(1.9) vs. 6.3 (2.7) h. The respective mean values (SD in parentheses) for MRT, AUC 0–α Cl/f, and V z f were 6.8 (0.4) vs. 6.8 (0.5) h, 0.547 (0.070) vs. 0.521(0.090)μg/h/mL, 8.54 (0.37) vs. 8.97 (1.46) mL/min/kg and 4.8 (1.7) vs. 5.1 (1.2) L/kg. There was no differencein the plasma concentrations or pharmacokinetics of primaquine between patients with normal G6PD and G6PD deficiency. In the G6PD deficient group, no relationship between the severity of haemolysis ( < 20% or > 20% haemolysis) and the concentrations/pharmacokinetics of primaquine was observed. © 1994 Oxford University Press. 2018-02-27T04:26:30Z 2018-02-27T04:26:30Z 1994-01-01 Article Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.88, No.2 (1994), 220-222 10.1016/0035-9203(94)90306-9 18783503 00359203 2-s2.0-0028331832 https://repository.li.mahidol.ac.th/handle/123456789/9575 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0028331832&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Immunology and Microbiology Medicine |
spellingShingle |
Immunology and Microbiology Medicine Kesara Na Bangchang Wasana Songsaeng Aurathai Thanavibul Preecha Choroenlarp Juntra Karbwang Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria |
description |
The pharmacokinetics of primaquine have been studied in 13 G6PD normal and 13 G6PD deficient Thai male patients with Plasmodium vivax malaria who were given daily doses of 15 mg of primaquine over 14 d, following a full course of chloroquine. After the first dose (15 mg), primaquine underwent rapid absorption. Mean values (SD in parentheses) of maximum plasma concentration of 57.7 (7.7) vs. 55.7 (7.4) ng/mL were reached at 2.2 (0.6) vs. 2.2 (0.6) h, for the G6PD deficient and G6PD normal groups, respectively. Thereafter, drug levels declined rapidly and monoexponentially with a t 1/2λ of 6.4(1.9) vs. 6.3 (2.7) h. The respective mean values (SD in parentheses) for MRT, AUC 0–α Cl/f, and V z f were 6.8 (0.4) vs. 6.8 (0.5) h, 0.547 (0.070) vs. 0.521(0.090)μg/h/mL, 8.54 (0.37) vs. 8.97 (1.46) mL/min/kg and 4.8 (1.7) vs. 5.1 (1.2) L/kg. There was no differencein the plasma concentrations or pharmacokinetics of primaquine between patients with normal G6PD and G6PD deficiency. In the G6PD deficient group, no relationship between the severity of haemolysis ( < 20% or > 20% haemolysis) and the concentrations/pharmacokinetics of primaquine was observed. © 1994 Oxford University Press. |
author2 |
Mahidol University |
author_facet |
Mahidol University Kesara Na Bangchang Wasana Songsaeng Aurathai Thanavibul Preecha Choroenlarp Juntra Karbwang |
format |
Article |
author |
Kesara Na Bangchang Wasana Songsaeng Aurathai Thanavibul Preecha Choroenlarp Juntra Karbwang |
author_sort |
Kesara Na Bangchang |
title |
Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria |
title_short |
Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria |
title_full |
Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria |
title_fullStr |
Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria |
title_full_unstemmed |
Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria |
title_sort |
pharmacokinetics of primaquine in g6pd deficient and g6pd normal patients with vivax malaria |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/9575 |
_version_ |
1763489379610787840 |